Comparing two types of lung surgery for early-stage lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study compares two types of lung surgery for early-stage lung cancer: removing only the tumor part (segmentectomy) versus removing a larger portion (lobectomy). The goal is to see if the less invasive surgery works just as well while preserving more healthy lung tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You have early-stage non-small cell lung cancer (stage IA3) — the tumor is between 2 and 3 centimeters across and has not spread to lymph nodes or other parts of the body.
- You are well enough to have surgery (your heart and lungs are strong enough), and your doctor thinks removing just the tumor area (segmentectomy) or a larger part of the lung (lobectomy) is possible.
- During the surgery, your doctor will check nearby lymph nodes. If they contain cancer, the surgery will be changed to remove more of the lung (lobectomy) as standard care, and you won't be part of the study's main analysis.
- You have not had surgery on the same lung before (like a lobectomy or segmentectomy), and you have no other cancer within the last 5 years (except cured low-risk ones).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of lung cancer surgery for early-stage tumors: removing only the part of the lung with the tumor (segmentectomy) versus removing the entire lobe (lobectomy). It aims to see if the smaller surgery works just as well and might be easier to recover from.
This study compares two types of lung surgery for people with early-stage non-small cell lung cancer (a common type of lung cancer). One surgery removes a small part of the lung (segment), the other removes an entire lobe (a larger section of the lung). The goal is to see which approach offers better outcomes for tumors that are between 2 and 3 centimeters across and are solid (not just ground-glass).
This trial looks back at medical records to compare different ways of performing a segmentectomy (removing a small part of the lung) for early-stage lung cancer. It aims to see which approach might lead to better outcomes for patients like you.
This study compares two types of lung cancer surgery—removing just the tumor section (segmentectomy) or the whole lobe (lobectomy)—done through small cuts (minimally invasive). The goal is to see which approach leads to better daily living and recovery for early-stage lung cancer patients.
This trial tests a new surgical technique to remove small, early-stage lung cancers that are located deep within the lung tissue. The goal is to remove only the affected area while preserving as much healthy lung as possible.
This study compares two treatments—removing only part of the lung (sublobar resection) versus a focused radiation approach (stereotactic ablative radiotherapy)—for early-stage non-small cell lung cancer. It aims to see which option works better with fewer problems for the right patients.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.